At the European Society for Medical Oncology 2023 Congress, Dr. DeMichele presented results from the CLEVER study, which looked at ways to treat inactive breast cancer cells that remained in people who were previously treated for breast cancer. The results suggest that it might be possible to find and treat these inactive breast cancer cells, which could help prevent breast cancer recurrence (the cancer coming back).

Listen to the podcast to hear Dr. DeMichele explain:

how inactive breast cancer cells survive chemotherapy

how the inactive cells wake up and cause a recurrence

the results of the CLEVER study

next steps for the research